top of page

Singular Health (ASX SHG), Research and Coverage

singular-health-group-limited

Singular Health Group Limited (ASX: SHG) is a medical imaging software company based in Perth. It listed on the ASX on 12 February 2021 (ASX company data). Its 3DICOM software is built to let doctors, health networks and patients find, view and share medical scans. The desktop and cloud versions of its 3DICOM MD viewer have clearance from the United States Food and Drug Administration (ASX announcement, 13 January 2026). Revenue was A$1.43 million in the year to 30 June 2026, mostly from the United States. The loss after tax was A$6.34 million (annual report, lodged 31 August 2026). Cash was A$8.14 million at 30 September 2026 (Appendix 4C, lodged 27 October 2026). Samso had published 4 pieces on the company at 19 November 2026.

ASX code: SHG. Full legal name: Singular Health Group Limited. Managing Director and Chief Executive Officer: Denning Chong. Howard Digby is the non-executive chairman. The other director is Andrew Just, who is non-executive (annual report, lodged 31 August 2026). Singular Health held A$8.14 million in cash at 30 September 2026 and reported no debt (quarterly report and Appendix 4C, lodged 27 October 2026).

What Singular Health sells

Singular Health sells software for medical imaging under the 3DICOM name. DICOM is the standard file format for medical scans such as CT and MRI. The company says scans that cannot be found are often repeated, and that health plans carry much of that cost. Its software is built to let an authorised doctor find and view a scan taken somewhere else (quarterly report, lodged 27 October 2026, and ASX announcement, 29 September 2026).

  • 3DICOM MD. A viewer that doctors use to look at scans in two and three dimensions. It is licensed in the United States at US$800 per physician per year.
  • 3DICOM Gateway. A tool that looks for a patient's earlier imaging before a new scan is ordered.
  • 3DICOM Patient. Secure digital access to scans for patients and referring doctors, in place of a CD.
  • 3DICOM EDU. A version for anatomy teaching and healthcare training.
  • MFTP. The Medical File Transfer Protocol is the company's technology for moving large imaging files between systems. An Australian patent for the system behind it was granted on 1 October 2026.
  • ImageIQ. An artificial intelligence module meant to help a doctor choose the appropriate scan. It is in development and is not yet commercially released.

The descriptions above are from the quarterly report lodged 27 October 2026 and the company presentation lodged 1 October 2026. Revenue from customers was A$1,428,231 in the year to 30 June 2026. Of that, A$1,376,819 came from the United States and A$51,412 from Australia (annual report, note 5, lodged 31 August 2026).

Singular Health regulatory clearances

Singular Health announced on 13 January 2026 that the United States Food and Drug Administration, the FDA, had granted 510(k) clearance for 3DICOM MD Cloud. A 510(k) is a premarket notification filed with the FDA. Clearance confirms substantial equivalence to an earlier device, known as the predicate (ASX announcement, 28 November 2025). The product was cleared as a Class II Software as a Medical Device, meaning the software itself is regulated as a medical device. The company said the clearance allows marketing and clinical use of the product in the United States (ASX announcement, 13 January 2026).

The cloud version runs in a web browser. It handles X-ray and ultrasound as well as the CT, MRI and PET scans covered by the desktop version. The desktop 3DICOM MD software received its FDA clearance in October 2022, and the company used that clearance as the base for the new filing (ASX announcement, 13 January 2026).

Singular Health also reports compliance with HIPAA, the United States law of 1996 that protects the privacy and security of patient health information, and with the ISO 27001 and SOC 2 Type II security standards. The annual report lists Australian, Canadian and European certifications as further ones the company has identified for diagnostic use of 3DICOM. It notes that new products or features may need further clearances and clinical studies, with no guarantee they will meet the standards for commercial release (annual report, lodged 31 August 2026).

Singular Health customers in the United States

Singular Health's largest customer agreement is with Provider Network Solutions, or PNS. PNS is a managed service organisation, a business that manages healthcare services for networks of doctors and health plans. It operates in Florida, Texas and Puerto Rico.

The agreement was announced on 19 June 2025 with a total value of US$1.3 million, which the company put at about A$2.0 million. It comprises US$800,000 for 1,000 3DICOM licences at US$800 each a year and US$500,000 of one-off fees for development and integration work, payable as that work is delivered. The initial term was one year from 1 July 2025, with automatic renewal for a year on each anniversary unless the parties agree not to extend or the contract is terminated. The licences renew for a year at a time by mutual agreement (ASX announcement, 19 June 2025).

On 22 April 2026 the company reported receiving US$500,000 from PNS, which it described as the balance of the licence fees (ASX announcement, 22 April 2026). A presentation lodged on 1 October 2026 gave 750 licences deployed and 250 remaining. The quarterly report lodged 27 October 2026 says the 1,000 contracted licences have been deployed. On renewal, the annual report lodged 31 August 2026 had the licensing arrangement due to expire in the September 2026 quarter. The quarterly report has the agreement due for renewal by 31 December 2026, with talks on renewal and expansion continuing. No renewal had been announced at 19 November 2026.

Singular Health and PNS also share a United States joint venture company, Singular Imaging Solutions-US, Inc. On 30 July 2026 the group bought shares in it from Marin & Sons Strategies LLC for US$175,000, lifting its holding from 30 per cent to about 60 per cent. PNS entities hold the rest (annual report, note 28, lodged 31 August 2026).

The second agreement is a memorandum of understanding, or MOU, with Florida International University, announced on 29 September 2026. Medicaid is the United States public health insurance program for people on low incomes. The State of Florida set aside US$3.0 million, about A$4.17 million, for the university to build a medical imaging repository for Florida Medicaid providers. A repository here is a secure store where scans from many providers can be found and shared. Under the MOU Singular Health would design, deliver and operate it for about 85 per cent of the funding, about US$2.55 million or A$3.5 million. Payment would be made on milestones, with the full amount due by 30 June 2027 subject to delivery (ASX announcement, 29 September 2026).

The company describes the MOU as non-binding, except that the parties are legally bound to enter definitive agreements on its minimum terms. Those agreements were still to be signed when the quarterly report was lodged. The funding is for a single year and lapses if unspent by 30 June 2027. Follow-on funding, the announcement says, is not assured (ASX announcement, 29 September 2026, and quarterly report, lodged 27 October 2026).

Smaller deployments include 3DICOM Gateway and 3DICOM Patient in operation at Life Radiology in Florida and a paid pilot of 3DICOM EDU at Miami-Dade County Public Schools. Talks with other health plans and networks, including Triple-S, were at discussion or pilot stage (quarterly report, lodged 27 October 2026).

Singular Health revenue, losses and cash

Singular Health's revenue from customers rose to A$1.43 million in the year to 30 June 2026, from A$203,069 a year earlier. The loss after tax was A$6.34 million, against A$6.38 million, which included a A$0.11 million loss from a discontinued business. Expenses included A$2.09 million of share-based payments, which are a non-cash cost. Receipts from customers were A$778,865, including GST. Operations used A$5.30 million of cash, against A$2.34 million (annual report, lodged 31 August 2026).

At 30 June 2026 the group held A$2.36 million in cash and A$7.70 million in term deposits. Total liabilities were A$0.70 million and net assets were A$10.54 million. The directors state that the group has enough financial resources for at least twelve months from the date of the report. Among its risks, the report says the group will need more funding as the business grows, with no assurance it can be obtained on favourable terms (annual report, lodged 31 August 2026).

In the September 2026 quarter the company received A$10,000 from customers and used A$1.918 million in operations. The report notes that the US$800,000 PNS payment was received in the previous financial year. Cash went from A$10.07 million to A$8.14 million. The Appendix 4C, the quarterly cash flow form, divides the cash by the quarter's operating outflow and gives 4.25 quarters of funding. That figure leaves out any receipts from the Florida repository. A research and development tax refund of A$0.47 million was expected in the December 2026 quarter (quarterly report and Appendix 4C, lodged 27 October 2026).

The annual report lists two substantial holders, Marin & Sons Strategies LLC with 6.37 per cent and Denning Chong with 5.38 per cent (annual report, lodged 31 August 2026). The presentation lodged on 1 October 2026 shows Marin & Sons at 8.56 per cent and PNS at 1.89 per cent. The notice of meeting, lodged 6 October 2026, set the annual general meeting for 26 November 2026.

Every Samso piece on Singular Health

4 published pieces as at 19 November 2026, grouped by Samso product. Newest first in each group. Dates are Perth dates.

Samso Insights

Samso News

Coffee with Samso

Videos on YouTube

Questions people ask about Singular Health (ASX SHG)

What does Singular Health do? It develops and sells 3DICOM, software built to let doctors, health networks and patients find, view and share medical scans. Its customers are mainly in the United States.

What is the Singular Health share price? The ASX website shows the SHG share price. This page lists Samso's coverage and has no live price.

What is the latest announcement from Singular Health? As at 19 November 2026 the newest item on the ASX list was the quarterly activities and cash flow report for the September 2026 quarter, lodged on 27 October 2026.

Is 3DICOM cleared by the FDA? Two versions of the 3DICOM MD viewer are. The company reports FDA 510(k) clearance for the desktop software in October 2022 and for 3DICOM MD Cloud in January 2026 (ASX announcement, 13 January 2026).

Is Singular Health worth looking at? This page gives no buy, sell or hold call, price target or valuation. Revenue from customers was A$1.43 million in the year to 30 June 2026, up from A$203,069. The loss after tax was A$6.34 million. Cash was A$8.14 million at 30 September 2026, with no debt. The Florida MOU still needed definitive agreements at 27 October 2026, and no renewal of the PNS agreement had been announced at 19 November 2026. Samso had published no research workup on Singular Health at 19 November 2026. The Samso News piece of 28 January 2026 is the most recent.

Disclosure

Samso's News piece of 28 January 2026 says "Samso has had a long association with Singular Health". Singular Health was a Samso client. That arrangement has ended. Samso holds no shares in Singular Health.

This page is general information only.

Depth over hype.

Samso company research pages are independent research commentary for general information only. Nothing on this page is financial product advice, and it does not take into account any reader's objectives, financial situation or needs. Figures are drawn from public sources believed reliable at the stated dates but are not guaranteed, and market-sensitive numbers change daily. Samso or associated parties may hold positions in, or have commercial arrangements with, companies mentioned. Seek professional advice before making investment decisions. © Samso 2026, samso.com.au

Page last reviewed 19 November 2026.

bottom of page